期刊文献+

鹅细小病毒VP3基因疫苗两种不同免疫方式对细胞免疫的影响 被引量:5

Effects of two immunization methods of goose parvovirus VP3 gene vaccine on cellular immune responses
下载PDF
导出
摘要 将构建的鹅细小病毒(GPV)VP3基因疫苗(pcDNA-GPV-VP3)转染鹅胚成纤维细胞(GEF),每隔12h检测VP3蛋白的表达情况,同时以不同剂量分别通过基因枪轰击和肌肉注射免疫28日龄健康雏鹅,于免疫后第3、7、14、21、28、35、49、63、77和105d采血,进行淋巴细胞增殖试验(MTT法)。结果,转染后第24h即可在GEF中检测到GPVVP3蛋白,第60h表达量达到高峰。试验组鹅外周血T淋巴细胞D490nm值在免疫后第35d达到最大。肌肉注射组和基因枪组免疫后第14~63d、第7~63d的D490nm值分别与PBS对照组差异板显著;肌肉注射组及基因枪组免疫后第21~49d的D490nm值显著高于弱毒疫苗对照组;肌肉注射组及基因枪组免疫后第14~63d的D490nm值板显著高于空质粒对照组。表明,基因枪轰击和肌肉注射pcDNA—GPV—VP3均能诱导雏鹅产生良好的细胞免疫应答。 A plasmid pcDNA-GPV-VP3 was transfected into goose embryo fibroblast cells(GEFs),and the expression of VP3 protein was detected every 12 hours. 28-day-old healthy goslings were immunized with different dosages of pcDNA-GPV-VP3 by gene gun bombardment and intramuscular injection(i. m. ), respectively. Blood samples collected on day 3,7,14,21,28,35,49,63,77 and 105 post-immunization (PI) were measured by T-lymphocyte proliferation test. In results,the VP3 gene of goose parvovirus(GPV) was successfully expressed in GEFs at hour 24 PI and the expression reached peek at hour 60 PI. D490nm of T-lymphocyte cells from the immunized goslings reached peak on day 35 PI. D490nm in the i. m. and gene gun bombardment groups were very significantly higher than that in the PBS control group on day 14-63 and 7-63 PI respectively,and significantly higher than that in the GPV attenuated vaccine group on day 14 -63 PI and that in the empty plasmid group on day 21-49 PI. The results showed that the good cellular immunity effects were induced with pcDNA-GPV-VP3 by i. m. and gene gun bombardment.
出处 《中国兽医科学》 CAS CSCD 北大核心 2007年第5期401-405,共5页 Chinese Veterinary Science
基金 国家科技攻关重大项目(2004BA901A03) 教育部"新世纪优秀人才支持计划"项目(NCET-04-0906) 四川省基础研究重大项目(04JY029-006-1) 四川省重点建设学科项目(SZD0418)
关键词 鹅细小病毒VP3基因疫苗 细胞免疫 基因枪轰击 肌肉注射 pcDNA-GPV-VP3 DNA vaccine cellular immunity gene gun bombardment intramuscular injection
  • 相关文献

参考文献19

二级参考文献57

  • 1刘民,马华,李柏青.MTT法检测小鼠淋巴细胞增殖性反应探讨[J].中国实验动物学杂志,1999,9(3):146-149. 被引量:63
  • 2MacGregor RR, Boyer JD, Ugen KE et al. First human trial of a DNA- based vaccine for.treatment of human immunodeficiency virus type Ⅰ infection:safety and host response. J Infect Dis,1998,178(1):92. 被引量:1
  • 3Roy MJ, Wu MS, Barr LJ et al. Induction of antigen-specific CD8^+ T helper cells, and protective levels of antibody in humans by particle-mediated administration of hepatitis B virus DNA vaccine, Vaccine, 2001(7--8),19:764. 被引量:1
  • 4Wang R,Doolan DL, Le TP et al. Induction of antigen-specific cytoxic T lymphocytes in humans by a malaria DNA vaccine. Science, 1998,282(5388): 476. 被引量:1
  • 5Parker SE, Borellini F, Wenk ML et al. Plasmid DNA malaria vaccine:Tissue distribution and safety studies in mice and rabbits. Hum Gene Ther, 1999,10(5) : 741. 被引量:1
  • 6Parker SE, Monteith D, Horton Het al. Safety of a GM-CSF adjuvantplasmid DNA malaria vaccine. Gene Ther, 2001,8(13):1011. 被引量:1
  • 7Danko I, Wolff JA. Direct gene transfer into muscle. Vaccine, 1994, 12(16):1499. 被引量:1
  • 8Chow YH, Chiang BL, Lee YL et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can he modulated by co-delivery of various cytokine genes. J Immunol, 1998,160(3): 1320. 被引量:1
  • 9Loirat D,Virology,1999年,260卷,74页 被引量:1
  • 10袁正宏,中华微生物学和免疫学杂志,1999年,19卷,25页 被引量:1

共引文献32

同被引文献45

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部